Liquidia Corp share price today

(LQDA)

Liquidia Corp share price is $11.09 & ₹939.66 as on 5 Dec 2024, 2.30 'hrs' IST

$11.09

▲

-0.17

(-1.51%)

Market is closed - opens 8 PM, 05 Dec 2024

View live Liquidia Corp share price in Dollar and Rupees. Guide to invest in Liquidia Corp from India. Also see the sentimental analysis on Indian investors investing in Liquidia Corp. Get details on the Indian mutual funds that are investing in Liquidia Corp. Get Analyst recommendations and forecasts along with all the Liquidia Corp's financials.

Liquidia Corp share price movements

$11.03
$11.44
$11.09
0.54%
Downside
Day's Volatility :3.58%
Upside
3.06%
$6.83
$16.99
$11.09
38.41%
Downside
52 Weeks Volatility :59.8%
Upside
34.73%

Liquidia Corp Returns

Period	Liquidia Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	24.09%	-4.7%	0.0%
6 Months	-19.32%	0.9%	0.0%
1 Year	56.41%	11.6%	0.0%
3 Years	138.94%	12.9%	-18.1%

Liquidia Corp Key Statistics

in dollars & INR

Previous Close	$11.26
Open	$11.21
Today's High	$11.44
Today's Low	$11.03
Market Capitalization	$983.1M
Today's Volume	$617.6K
52 Week High	$16.99
52 Week Low	$6.83
Revenue TTM	$14.8M
EBITDA	$-95.8M
Earnings Per Share (EPS)	$-1.62
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-181.73%

How to invest in Liquidia Corp from India?

It is very easy for Indian residents to invest directly in Liquidia Corp from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Liquidia Corp stock in both rupees (INR) and dollars (USD). Search for Liquidia Corp or LQDA on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Liquidia Corp or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Liquidia Corp shares which would translate to 0.076 fractional shares of Liquidia Corp as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Liquidia Corp

-62%

Period: Sep 5, 2024 to Dec 4, 2024. Change in 30 Days versus previous period

Search volume for Liquidia Corp on INDmoney from India has reduced in the last 30 days as on Dec 5, 2024. -62% less investors are searching Liquidia Corp in the last 30 days versus the previous period.

Global Institutional Holdings in Liquidia Corp

Caligan Partners LP
9.59%
Patient Square Capital
8.49%
BlackRock Inc
5.01%
Vanguard Group Inc
4.07%
Farallon Capital Management, L.L.C.
3.89%
Findell Capital Management LLC
3.77%

Analyst Recommendation on Liquidia Corp

Buy

84%Buy

7%Hold

7%Sell

Based on 13 Wall street analysts offering stock ratings for Liquidia Corp(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Liquidia Corp

What analysts predicted

Upside of 129.44%

Current:

$11.09

Target:

$25.44

Insights on Liquidia Corp

Increasing Revenue
Revenue is up for the last 3 quarters, 2.97M → 4.44M (in $), with an average increase of 18.3% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -40.92M → -23.15M (in $), with an average increase of 33.6% per quarter

Liquidia Corp Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$2.7M	↓ 62.7%
Net Income	$-53.1M	↑ 82.26%
Net Profit Margin	-2.0K%	↓ 1561.24%

	FY19	Y/Y Change
Revenue	$8.1M	↑ 198.2%
Net Income	$-46.4M	↓ 12.7%
Net Profit Margin	-574.69%	↑ 1388.23%

	FY20	Y/Y Change
Revenue	$739.6K	↓ 90.84%
Net Income	$-57.5M	↑ 23.93%
Net Profit Margin	-7.8K%	↓ 7198.3%

	FY21	Y/Y Change
Revenue	$12.9M	↑ 1637.81%
Net Income	$-29.8M	↓ 48.2%
Net Profit Margin	-231.7%	↑ 7541.29%

	FY22	Y/Y Change
Revenue	$15.9M	↑ 23.98%
Net Income	$-38.4M	↑ 28.82%
Net Profit Margin	-240.76%	↓ 9.06%

	FY23	Y/Y Change
Revenue	$17.5M	↑ 9.75%
Net Income	$-78.5M	↑ 104.62%
Net Profit Margin	-448.89%	↓ 208.13%

	Q2 FY23	Q/Q Change
Revenue	$4.8M	↑ 6.52%
Net Income	$-23.5M	↑ 79.05%
Net Profit Margin	-491.37%	↓ 199.05%

	Q3 FY23	Q/Q Change
Revenue	$3.7M	↓ 23.15%
Net Income	$-15.8M	↓ 32.86%
Net Profit Margin	-429.31%	↑ 62.06%

	Q4 FY23	Q/Q Change
Revenue	$4.5M	↑ 23.19%
Net Income	$-27.5M	↑ 73.84%
Net Profit Margin	-605.83%	↓ 176.52%

	Q1 FY24	Q/Q Change
Revenue	$3.0M	↓ 34.41%
Net Income	$-40.9M	↑ 49.1%
Net Profit Margin	-1.4K%	↓ 771.29%

	Q2 FY24	Q/Q Change
Revenue	$3.7M	↑ 23.12%
Net Income	$-27.9M	↓ 31.73%
Net Profit Margin	-763.65%	↑ 613.47%

	Q3 FY24	Q/Q Change
Revenue	$4.4M	↑ 21.56%
Net Income	$-23.2M	↓ 17.13%
Net Profit Margin	-520.57%	↑ 243.08%

	FY18	Y/Y Change
Total Assets	$49.4M	↑ 232.93%
Total Liabilities	$30.7M	↓ 36.68%

	FY19	Y/Y Change
Total Assets	$68.8M	↑ 39.3%
Total Liabilities	$33.9M	↑ 10.3%

	FY20	Y/Y Change
Total Assets	$99.5M	↑ 44.58%
Total Liabilities	$28.4M	↓ 16.08%

	FY21	Y/Y Change
Total Assets	$93.7M	↓ 5.83%
Total Liabilities	$28.5M	↑ 0.06%

	FY22	Y/Y Change
Total Assets	$129.2M	↑ 37.84%
Total Liabilities	$38.8M	↑ 36.23%

	FY23	Y/Y Change
Total Assets	$118.3M	↓ 8.41%
Total Liabilities	$71.0M	↑ 83.2%

	Q2 FY23	Q/Q Change
Total Assets	$121.6M	↓ 5.68%
Total Liabilities	$60.9M	↑ 28.89%

	Q3 FY23	Q/Q Change
Total Assets	$111.6M	↓ 8.19%
Total Liabilities	$63.6M	↑ 4.42%

	Q4 FY23	Q/Q Change
Total Assets	$120.4M	↑ 7.87%
Total Liabilities	$73.1M	↑ 14.93%

	Q1 FY24	Q/Q Change
Total Assets	$197.1M	↑ 63.68%
Total Liabilities	$110.9M	↑ 51.57%

	Q2 FY24	Q/Q Change
Total Assets	$177.4M	↓ 10.02%
Total Liabilities	$114.6M	↑ 3.41%

	Q3 FY24	Q/Q Change
Total Assets	$252.9M	↑ 42.58%
Total Liabilities	$142.4M	↑ 24.19%

	FY18	Y/Y Change
Operating Cash Flow	$-31.8M	↑ 31.04%
Investing Cash Flow	$-870.9K	↓ 65.77%
Financing Cash Flow	$68.8M	↑ 138.83%

	FY19	Y/Y Change
Operating Cash Flow	$-48.3M	↑ 51.69%
Investing Cash Flow	$-1.9M	↑ 112.42%
Financing Cash Flow	$66.4M	↓ 3.52%

	FY20	Y/Y Change
Operating Cash Flow	$-54.1M	↑ 12.14%
Investing Cash Flow	$247.9K	↓ 113.4%
Financing Cash Flow	$63.4M	↓ 4.48%

	FY21	Y/Y Change
Operating Cash Flow	$-34.0M	↓ 37.14%
Investing Cash Flow	$-107.2K	↓ 143.25%
Financing Cash Flow	$26.3M	↓ 58.5%

	FY22	Y/Y Change
Operating Cash Flow	$-28.6M	↓ 16.01%
Investing Cash Flow	$-587.0K	↑ 447.47%
Financing Cash Flow	$65.0M	↑ 146.82%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-5.6M	↓ 34.21%
Investing Cash Flow	$-243.0K	↑ 0.0%
Financing Cash Flow	$-409.0K	↓ 104.11%

Liquidia Corp Technicals Summary

Sell

Neutral

Buy

Liquidia Corp is currently in a neutral trading position according to technical analysis indicators.

Liquidia Corp Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Liquidia Corp	7.67%	-19.32%	56.41%	138.94%	138.94%
Regeneron Pharmaceuticals, Inc.	-8.09%	-23.83%	-8.78%	21.97%	108.5%
Biontech Se	5.61%	15.12%	15.65%	-58.12%	304.14%
Alnylam Pharmaceuticals, Inc.	-4.63%	69.46%	44.56%	42.94%	109.6%
Vertex Pharmaceuticals Incorporated	-6.83%	-4.08%	31.76%	127.12%	112.3%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Liquidia Corp	NA	NA	NA	-1.63	-1.82	-0.41	NA	0.69
Regeneron Pharmaceuticals, Inc.	18.55	18.55	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.23	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Liquidia Corp	Buy	$983.1M	138.94%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$83.0B	108.5%	18.55	33.61%
Biontech Se	Buy	$28.9B	304.14%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	109.6%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$120.6B	112.3%	32.84	-4.51%

About Liquidia Corp

liquidia technologies is a biopharmaceutical company transforming the development of new therapies by precisely engineering drug particles. our proprietary print technology is a simple, elegant solution that solves common problems with drug delivery and efficacy. print technology is a scalable cgmp compliant process that creates particles and can apply to virtually any therapeutic area, molecule or route of administration. liquidia is bringing more efficient, controlled development capabilities to the industry while enhancing the safety and quality of products for patients. liquidia is advancing product candidates from its own pipeline. these initial product candidates, liq861 and liq865, apply the print technology to better drug delivery in inhaled and pain therapeutic areas, respectively. the print technology is also licensed with world-leading pharmaceutical companies that are developing future product candidates.

Organization	Liquidia Corp
Employees	145
CEO	Dr. Roger A. Jeffs Ph.D.
Industry	Health Technology

Management People of Liquidia Corp

Name	Title
Dr. Roger A. Jeffs Ph.D.	CEO & Director
Mr. Michael Kaseta	COO & CFO
Mr. Russell Schundler	General Counsel & Corporate Secretary
Mr. William R. Kenan Jr.	Co-Founder
Dr. Ginger Denison	Co-Founder
Ms. Sarah Krepp SPHR	Vice President of People & Culture
Mr. Jason Adair	Chief Business Officer
Mr. Scott Moomaw	Chief Commercial Officer
Dr. Rajeev Saggar M.D.	Chief Medical Officer
Mr. Michael Hunter	Senior Vice President of Manufacturing Operations

Important FAQs about investing in Liquidia Corp from India :

What is Liquidia Corp share price today?

Liquidia Corp (LQDA) share price today is $11.09.

Can Indians buy Liquidia Corp shares?

Yes, Indians can invest in the Liquidia Corp (LQDA) from India.

With INDmoney, you can buy Liquidia Corp at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Liquidia Corp at zero transaction cost.

How can I buy Liquidia Corp shares from India?

It is very easy to buy Liquidia Corp from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Liquidia Corp be purchased?

Yes, you can buy fractional shares of Liquidia Corp with INDmoney app.

What are the documents required to start investing in Liquidia Corp stocks?

To start investing in Liquidia Corp, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.